24 min listen
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
Ophthea's Transformative Shift, Clinical Successes, and Visionary Innovation
ratings:
Length:
43 minutes
Released:
Nov 17, 2023
Format:
Podcast episode
Description
Opthea, an Australian based biopharmaceutical company is dedicated to transforming retinal disease treatments and elevating patients' vision and quality of life. Join Firas Rahal, MD, in a captivating episode as he engages with Opthea's Founder and Chief Innovation Officer, Megan Baldwin, PhD.Explore the compelling journey from oncology to ophthalmology, unraveling strategic decisions, navigating competitive landscapes, and achieving triumphs in clinical trials. Dr. Baldwin unfolds her remarkable career trajectory, from a PhD at the University of Melbourne to pivotal roles at Genentech and the Ludwig Institute for Cancer Research.Tune in for exclusive insights, including:Opthea's strategic approach to revolutionizing eye careClinical Trials: A deep dive into their success and impactComparison with Other Drugs: Differentiating factors and unique contributionsFuture Directions: Exploring new horizons and clinical opportunitiesCommercialization Timeline: Anticipated milestones and FDA approval strategiesListen now for a compelling journey through Opthea's vision as they continue to shape the landscape of ophthalmological advancements.Opthea: Opthea.comMegan Baldwin, PhD: LinkedInFiras Rahal, MD ois.net/robert-rothman-md
Released:
Nov 17, 2023
Format:
Podcast episode
Titles in the series (100)
Hear How Avedro’s Muller Is Building A Cross-Linking Powerhouse by OIS Podcast | Ophthalmology's leading Podcast